Skip to content

Author

Kentaro Washizawa

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

IRO-203: a novel intranasal COVID-19 vaccine showing immunogenicity and viral suppression in African green monkey challenge study

Findings highlight the ability of IRO‑203 to induce measurable immune responses and to partially reduce viral RNA levels in a non-human primate challenge model and suggest that the nT-SeV vector represents an attractive platform for developing vaccines against other respiratory infectious diseases.

Kohji Kusano, Shinnosuke Suzuki, Kentaro Washizawa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.